A A
UnknownUnknownN/A📅 Scored March 31, 2026
Price at analysis: $115.48
Crucible Score
59.5
C+Quality × Value Composite
KQI — Quality
66.6
B-Fundamental Quality Index
KVI — Value
50.9
C-Valuation Attractiveness Index
Crucible Verdict — A
A delivers solid financial quality (81) and diversification (76) that overshadow its weak growth profile (52) and below-average value proposition (KVI 50.9). The stock trades at a 14% discount to fair value despite a strong 79% earnings beat rate, suggesting the market remains skeptical of management's ability to reignite growth momentum.
— Kal, Kaladin Capital Intelligence
◆ KQI Quality Dimensions
Financial Quality
80.6
Growth Profile
52.2
Moat Durability
60.3
Management Effectiveness⚠
64.8
Diversification & Resilience⚠
76.0
Market Position
72.0
Weakest dimension: Growth Profile (52.2)
◆ KVI Value Dimensions
DCF Margin of Safety
65.3
FCF Yield & Cash Returns
38.2
Relative Valuation
57.0
Growth-Adjusted Value
16.6
Historical Valuation
78.3
Macro Context
50.7
◆ DCF Valuation Scenarios
Bear Case
$89.52
Base Case
$131.45
Bull Case
$186.73
Price at Analysis
$115.48
| Scenario | Fair Value | Rev CAGR (5yr) | Terminal Margin | WACC |
|---|---|---|---|---|
| 🔴 Bear | $89.52 | 2.0% | 19.0% | 11.9% |
| 🟢 Base | $131.45 | 4.0% | 21.5% | 10.9% |
| 🟢 Bull | $186.73 | 6.0% | 24.0% | 10.1% |
Key Assumptions: Agilent (A) has shown relatively flat revenue (~$6.3-6.9B range) with stable EBITDA margins of 20-24% over the trailing 5 years, implying low single-digit organic growth. WACC is derived using CAPM with a 4% risk-free rate, 1.31 beta, and 5.5% ERP (healthcare diagnostics sector), yielding ~11.2% base cost of equity; with modest leverage the base WACC is ~10.9%. Tax rate is normalized at 12% reflecting the historical average which includes favorable jurisdictional mix. Bear case assumes macro headwinds compress margins to 19% with 2% revenue CAGR; bull case assumes life sciences recovery drives 6% CAGR with margin expansion to 24%.
◆ Financial Snapshot
Profitability
Gross Margin52.2%
Operating Margin20.6%
Net Margin18.3%
ROIC12.6%
ROE17.8%
Balance Sheet
Balance SheetCR: 2.07
Cash ConversionFCF/EPS: 0.77x
Capital IntensityCapex/Rev: 5.9%
Altman Z-Score4.50 (Safe)
Piotroski F-Score6/9 (Good)
Growth
Revenue CAGR2.4% CAGR
Earnings CAGR1.9% CAGR
Growth ConsistencyCV: 1.03
Segment Breadth1/2 growing (50%)
Quarterly TrendRev↑, Margin↑
Earnings CredibilityTends to Beat
◆ Analyst Consensus & Leadership
Leadership & Governance
CEO Ownership< 1%
Insider ActivitySelling
Capital AllocationROIC 12.6% vs WACC 2.6%
Earnings Beat Rate79% (17/22)
◆ Related Companies in Our Universe
Other Unknown companies scored by the Crucible:
Analysis conducted March 31, 2026 based on most recent SEC filings. Updated quarterly, after new SEC filings.
Point-in-time fundamental analysis. Not investment advice. Scores reflect company quality and valuation at time of analysis and may not reflect current market conditions.
© 2026 Kaladin Capital Intelligence — Conviction Through Scrutiny